Aligos Therapeutics Inc (NASDAQ:ALGS)’s traded shares stood at 96005.0 during the last session, with the company’s beta value hitting 2.77. At the close of trading,
During the last session, Aligos Therapeutics Inc (NASDAQ:ALGS)’s traded shares were 0.11 million, with the beta value of the company hitting 2.69. At the end
In the last trading session, 75983.0 shares of the Aligos Therapeutics Inc (NASDAQ:ALGS) were traded, and its beta was 2.74. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne